Cortecs International Ltd. deal

DLVRY (U.K.) entered into a five-year agreement with the University of Newcastle (Australia) to develop oral therapeutic vaccines and diagnostic products based on the mucosal immune system.

The collaboration will include Helicobacter pylori antigens and diagnostic tests, an oral influenza vaccine delivery system, oral vaccines against upper respiratory infections caused by Pseudomonas aeruginosa and H. pylori, as well as other therapeutic vaccines not yet disclosed. Also included are a number of rapid non-invasive diagnostic tests. ...